Biochemical and hematologic changes after short-term space flight.
Clinical laboratory data from blood samples obtained from astronauts before and after 28 flights (average duration = 6 days) of the Space Shuttle were analyzed by the paired t-test and the Wilcoxon signed-rank test and compared with data from the Skylab flights (duration approximately 28, 59, and 84 days).  Angiotensin I and aldosterone were elevated immediately after short-term space flights, but the response of angiotensin I was delayed after Skylab flights.  Serum calcium was not elevated after Shuttle flights, but magnesium and uric acid decreased after both Shuttle and Skylab.  Creatine phosphokinase in serum was reduced after Shuttle but not Skylab flights, probably because exercises to prevent deconditioning were not performed on the Shuttle.  Total cholesterol was unchanged after Shuttle flights, but low density lipoprotein cholesterol increased and high density lipoprotein cholesterol decreased.  The concentration of red blood cells was elevated after Shuttle flights and reduced after Skylab flights.  Reticulocyte count was decreased after both short- and long-term flights, indicating that a reduction in red blood cell mass is probably more closely related to suppression of red cell production than to an increase in destruction of erythrocytes.  Serum ferritin and number of platelets were also elevated after Shuttle flights.  In determining the reasons for postflight differences between the shorter and longer flights, it is important to consider not only duration but also countermeasures, differences between spacecraft, and procedures for landing and egress.
Leach
C S
CS
NASA/Johnson Space Center, Houston, TX 77058.
D000222:Adaptation, Physiological; D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001798:Blood Proteins / Q000032:analysis; D002118:Calcium / Q000097:blood; D005260:Female; D006728:Hormones / Q000502:physiology*; D006801:Humans; D008274:Magnesium / Q000097:blood; D008297:Male; D013026:Space Flight; D013997:Time Factors; D014893:Weightlessness / Q000009:adverse effects*; D018544:Weightlessness Countermeasures
D001798:Blood Proteins; D006728:Hormones; D008274:Magnesium; D002118:Calcium